OBJECTIVE: Higher resting heart rate (rHR) and lower heart rate variability (HRV) are associated with increased risk of cardiovascular disease (CVD) and all-cause mortality in people with and without diabetes. It is unknown whether temporal changes in rHR and HRV may contribute to this risk. We investigated associations between 5-year changes in rHR and HRV and risk of future CVD and death, taking into account participants' baseline glycemic state. RESEARCH DESIGN AND METHODS: In this prospective, population-based cohort study we investigated 4,611 CVD-free civil servants (mean [SD] age, 60 [5.9] years; 70% men). We measured rHR and/or six indices of HRV. Associations of 5-year change in 5-min rHR and HRV with fatal and nonfatal CVD and all-cause mortality or the composite of the two were assessed, with adjustments made for relevant confounders. Effect modification by glycemic state was tested. RESULTS: At baseline, 63% of participants were normoglycemic, 29% had prediabetes, and 8% had diabetes. During a median (interquartile range) follow-up of 11.9 (11.4; 12.3) years, 298 participants (6.5%) experienced a CVD event and 279 (6.1%) died of non-CVD-related causes. We found no association between 5-year changes in rHR and HRV and future events. Only baseline rHR was associated with all-cause mortality. A 10 bpm-higher baseline HR level was associated with an 11.4% higher rate of all-cause mortality (95% CI 1.0-22.9%; P = 0.032). Glycemic state did not modify associations. CONCLUSIONS: Changes in rHR and HRV and possibly also baseline values of these measures are not associated with future CVD or death in people with or without dysglycemia.

Danish Diabetes Academy Odense Denmark

Department of Epidemiology and Public Health University College London London U K

Department of Internal Medicine and Cardiology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Internal Medicine and Oncology Semmelweis University Faculty of Medicine Budapest Hungary

Department of Public Health Aarhus University Aarhus Denmark

Department of Public Health Semmelweis University Faculty of Medicine Budapest Hungary

National Heart and Lung Institute Imperial College London U K

National Institute of Public Health Southern Denmark University Odense Denmark

Steno Diabetes Center Aarhus Aarhus Denmark

Steno Diabetes Center Copenhagen Gentofte Denmark

Zobrazit více v PubMed

Gregg EW, Cheng YJ, Srinivasan M, et al. . Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 2018;391:2430–2440 PubMed

Dekker JM, Crow RS, Folsom AR, et al. . Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk in Communities. Circulation 2000;102:1239–1244 PubMed

Tsuji H, Larson MG, Venditti FJ Jr., et al. . Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996;94:2850–2855 PubMed

Cooney MT, Vartiainen E, Laatikainen T, Juolevi A, Dudina A, Graham IM. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women [published correction appears in Am Heart J 2010;160:208]. Am Heart J 2010;159:612–619.e3 PubMed

Ho JE, Larson MG, Ghorbani A, et al. . Long-term cardiovascular risks associated with an elevated heart rate: the Framingham Heart Study. J Am Heart Assoc 2014;3:e000668. PubMed PMC

Lonn EM, Rambihar S, Gao P, et al. . Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol 2014;103:149–159 PubMed

Pop-Busui R, Braffett BH, Zinman B, et al. .; DCCT/EDIC Research Group . Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes Care 2017;40:94–100 PubMed PMC

Pop-Busui R, Evans GW, Gerstein HC, et al. .; Action to Control Cardiovascular Risk in Diabetes Study Group . Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010;33:1578–1584 PubMed PMC

Hillis GS, Woodward M, Rodgers A, et al. . Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia 2012;55:1283–1290 PubMed PMC

Aeschbacher S, Schoen T, Dörig L, et al. . Heart rate, heart rate variability and inflammatory biomarkers among young and healthy adults. Ann Med 2017;49:32–41 PubMed

Hillebrand S, Swenne CA, Gast KB, et al. . The role of insulin resistance in the association between body fat and autonomic function. Nutr Metab Cardiovasc Dis 2015;25:93–99 PubMed

Saito I, Hitsumoto S, Maruyama K, et al. . Heart rate variability, insulin resistance, and insulin sensitivity in Japanese adults: the Toon Health Study. J Epidemiol 2015;25:583–591 PubMed PMC

Rubin J, Blaha MJ, Budoff MJ, et al. . The relationship between resting heart rate and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2012;220:194–200 PubMed

Papanas N, Vinik AI, Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol 2011;7:682–690 PubMed

Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study, 1987-1998. Circulation 2003;107:2190–2195 PubMed

Wulsin LR, Horn PS, Perry JL, Massaro JM, D’Agostino RB. Autonomic imbalance as a predictor of metabolic risks, cardiovascular disease, diabetes, and mortality. J Clin Endocrinol Metab 2015;100:2443–2448 PubMed

Hansen CS, Færch K, Jørgensen ME, et al. . Heart rate, autonomic function, and future changes in glucose metabolism in individuals without diabetes: the Whitehall II cohort study. Diabetes Care 2019;42:867–874 PubMed PMC

Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009;373:2215–2221 PubMed PMC

Stringhini S, Batty GD, Bovet P, et al. . Association of lifecourse socioeconomic status with chronic inflammation and type 2 diabetes risk: the Whitehall II prospective cohort study. PLoS Med 2013;10:e1001479. PubMed PMC

American Diabetes Association . 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2018. Diabetes Care 2018;41(Suppl. 1):S13–S27 PubMed

Hinnouho GM, Czernichow S, Dugravot A, et al. . Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J 2015;36:551–559 PubMed PMC

Marmot M, Brunner E. Cohort profile: the Whitehall II study. Int J Epidemiol 2005;34:251–256 PubMed

Kivimäki M, Batty GD, Singh-Manoux A, Britton A, Brunner EJ, Shipley MJ. Validity of cardiovascular disease event ascertainment using linkage to UK hospital records. Epidemiology 2017;28:735–739 PubMed PMC

Carstensen B. Age-period-cohort models for the Lexis diagram. Stat Med 2007;26:3018–3045 PubMed

Janssen KJ, Donders AR, Harrell FE Jr., et al. . Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 2010;63:721–727 PubMed

van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007;16:219–242 PubMed

Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol 2009;9:57. PubMed PMC

Jandackova VK, Scholes S, Britton A, Steptoe A. Are changes in heart rate variability in middle-aged and older people normative or caused by pathological conditions? Findings from a large population-based longitudinal cohort study. J Am Heart Assoc 2016;5:e002365. PubMed PMC

Kannel WB, Kannel C, Paffenbarger RS Jr., Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489–1494 PubMed

Ziegler D, Zentai CP, Perz S, et al. .; KORA Study Group . Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care 2008;31:556–561 PubMed

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group . Risk factors for cardiovascular disease in type 1 diabetes. Diabetes 2016;65:1370–1379 PubMed PMC

Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984;226:180–182 PubMed

Custodis F, Schirmer SH, Baumhäkel M, Heusch G, Böhm M, Laufs U. Vascular pathophysiology in response to increased heart rate. J Am Coll Cardiol 2010;56:1973–1983 PubMed

Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 1999;159:585–592 PubMed

Swedberg K, Komajda M, Böhm M, et al. .; SHIFT Investigators . Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study [published correction appears in Lancet 2010;376:1988]. Lancet 2010;376:875–885 PubMed

Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R; BEAUTIFUL Investigators . Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008;372:817–821 PubMed

Hulmán A, Tabák AG, Nyári TA, et al. . Effect of secular trends on age-related trajectories of cardiovascular risk factors: the Whitehall II longitudinal study 1985-2009. Int J Epidemiol 2014;43:866–877 PubMed PMC

NHS Digital . Health Survey for England 2018. Accessed 26 January 2021. Available from http://healthsurvey.hscic.gov.uk/support-guidance/public-health/health-survey-for-england-2018.aspx

Malik M, Farrell T, Camm AJ. Circadian rhythm of heart rate variability after acute myocardial infarction and its influence on the prognostic value of heart rate variability. Am J Cardiol 1990;66:1049–1054 PubMed

Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553–1579 PubMed

Zobrazit více v PubMed

figshare
10.2337/figshare.13526351